Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis

被引:36
作者
Cejudo-Martín, P
Ros, J
Navasa, M
Fernández, J
Fernández-Varo, G
Ruiz-del-Arbol, L
Rivera, F
Arroyo, V
Rodés, J
Jiménez, W
机构
[1] Univ Barcelona, Hosp Clin Barcelona, Lab Hormonal, E-08036 Barcelona, Spain
[2] Univ Barcelona, Hosp Clin Barcelona, Liver Unit, Inst Malalties Digest, E-08036 Barcelona, Spain
[3] Univ Barcelona, Inst Invest Biomed August Pi I Sunyer, IDIBAPS, E-08036 Barcelona, Spain
[4] Univ Barcelona, IRSIN, E-08036 Barcelona, Spain
[5] Hosp Ramon y Cajal, Gastroenterol Unit, E-28034 Madrid, Spain
关键词
D O I
10.1053/jhep.2001.27093
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Spontaneous bacterial peritonitis (SBP) is a common complication of cirrhotic patients with ascites that usually results in renal failure and death despite the efficacy of the current antibiotic therapy. The pathogenesis of these phenomena is poorly known but it has been related to the production of vasoactive cell mediators locally acting on the splanchnic vasculature. Because previous studies showed that peritoneal macrophages of cirrhotic patients may produce high quantities of vascular endothelial growth factor (VEGF), a powerful vessel permeabilizing agent, when stimulated by cytokines and bacterial lipopolysaccharide, the present study was aimed to seek whether peritoneal macrophages of SBP patients are induced to produce increased amounts of VEGF. Our results indicate that the production rate and the messenger RNA (mRNA) and protein expression of this substance are increased in macrophages of patients with SBP in comparison with those of noninfected cirrhotic patients. This characteristic feature is absent in circulating monocytes of these patients. Moreover, enhanced endothelial cell proliferation induced by conditioned medium of macrophages isolated from the ascites of patients with SBP is abolished by anti-VEGF antibody, and peritoneal tissue of cirrhotic patients expresses both VEGF receptors, Flt-1 and KDR. These results, therefore, are consistent with the concept that locally released macrophage-derived VEGF may result in increased vascular permeability and plasma leakage in the peritoneal vessels of cirrhotic patients with SBP.
引用
收藏
页码:487 / 493
页数:7
相关论文
共 33 条
[1]   Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].
Barleon, B ;
Sozzani, S ;
Zhou, D ;
Weich, HA ;
Mantovani, A ;
Marme, D .
BLOOD, 1996, 87 (08) :3336-3343
[2]   Vascular endothelial growth factor and microvascular permeability [J].
Bates, DO ;
Lodwick, D ;
Williams, B .
MICROCIRCULATION, 1999, 6 (02) :83-96
[3]   VASCULAR ENDOTHELIAL GROWTH-FACTOR RECEPTOR LOCALIZATION AND ACTIVATION IN HUMAN TROPHOBLAST AND CHORIOCARCINOMA CELLS [J].
CHARNOCKJONES, DS ;
SHARKEY, AM ;
BOOCOCK, CA ;
AHMED, A ;
PLEVIN, R ;
FERRARA, N ;
SMITH, SK .
BIOLOGY OF REPRODUCTION, 1994, 51 (03) :524-530
[4]  
Chen B, 1999, INT J CANCER, V83, P10
[5]   Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation [J].
Claria, J ;
Lee, MH ;
Serhan, CN .
MOLECULAR MEDICINE, 1996, 2 (05) :583-596
[6]   VEGF(121), A VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) ISOFORM LACKING HEPARIN-BINDING ABILITY, REQUIRES CELL-SURFACE HEPARAN SULFATES FOR EFFICIENT BINDING TO THE VEGF RECEPTORS OF HUMAN-MELANOMA CELLS [J].
COHEN, T ;
GITAYGOREN, H ;
SHARON, R ;
SHIBUYA, M ;
HALABAN, R ;
LEVI, BZ ;
NEUFELD, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (19) :11322-11326
[7]  
Couffinhal T, 1997, AM J PATHOL, V150, P1673
[8]   ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASES BY VASCULAR ENDOTHELIAL GROWTH-FACTOR AND BASIC FIBROBLAST GROWTH-FACTOR IN CAPILLARY ENDOTHELIAL-CELLS IS INHIBITED BY THE ANTIANGIOGENIC FACTOR 16-KDA N-TERMINAL FRAGMENT OF PROLACTIN [J].
DANGELO, G ;
STRUMAN, I ;
MARTIAL, J ;
WEINER, RI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (14) :6374-6378
[9]   A SIMPLE METHOD FOR THE PURIFICATION OF HUMAN PERIPHERAL-BLOOD MONOCYTES - A SUBSTITUTE FOR SEPRACELL-MN [J].
DENHOLM, EM ;
WOLBER, FM .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 144 (02) :247-251
[10]   The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25